Diabetes Education for Type 1 Diabetes
(T1DES Trial)
Trial Summary
What is the purpose of this trial?
Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailored intervention T1DES and evaluates the effect of the T1DES intervention on diabetes outcomes in a pilot randomized clinical trial among Black young adults with T1D.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Diabetes Education for Type 1 Diabetes?
Research shows that diabetes education helps people with Type 1 diabetes better manage their condition, leading to improved blood sugar control and fewer complications. Studies indicate that structured education programs can enhance quality of life and are essential for effective diabetes care.12345
Is diabetes education safe for people with type 1 diabetes?
How is the Diabetes Education treatment for Type 1 Diabetes different from other treatments?
The Diabetes Education treatment for Type 1 Diabetes is unique because it focuses on providing structured education and support to help patients and their families understand and manage the condition effectively, rather than relying solely on medication. This approach emphasizes the importance of knowledge and lifestyle adjustments, such as diet and exercise, to improve blood sugar control and prevent complications.568910
Research Team
Teaniese L Davis, PhD, MPH
Principal Investigator
Principal Investigator
Eligibility Criteria
This study is for Black young adults aged 18-30 with Type 1 diabetes, who have a Hemoglobin A1c level over 7.5, can read English, and are members of Kaiser Permanente Georgia or Grady Health Systems. They must be able to text and give informed consent. Those with severe diabetes complications or cognitive impairments that prevent informed consent cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either traditional diabetes education or the T1DES intervention, attending 5 sessions over 3 months
Follow-up
Participants are monitored for changes in HbA1c and diabetes distress at 3-months and 6-months post-baseline
Treatment Details
Interventions
- Diabetes Education
- T1DES
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kaiser Permanente
Lead Sponsor
The Leona M. and Harry B. Helmsley Charitable Trust
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Emory University
Collaborator